ANTICOAGULANT SODIUM CITRATE
Active substance: trisodium citrate
SOLUTION · TRISODIUM CITRATE DIHYDRATE 40 mg/mL
United StatesActive
Marketing holder: Baxter Healthcare Corporation
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- TRISODIUM CITRATE DIHYDRATE · 40 mg/mL
Registration
- Registration number
- 0338-9669
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- EXTRACORPOREAL
Sources
- product · openFDA NDC · 0338-9669 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0338-9669 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0338-9669 · Verified 2026-10-09 · open in source